GSK3B and Alzheimer disease: Animal studies revealed that BSHTYZ improved spatial learning and memory by affecting specific molecular targets involved in AD, such as the glycogen synthase kinase-3β(GSK-3β)/cAMP response element binding protein (CREB) signaling pathway (Yang et al., 2021).